Morgan Rosel Wealth Management, LLC Moderna, Inc. Transaction History
Morgan Rosel Wealth Management, LLC
- $313 Million
- Q1 2025
A detailed history of Morgan Rosel Wealth Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Morgan Rosel Wealth Management, LLC holds 67 shares of MRNA stock, worth $1,823. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67Holding current value
$1,823% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
925Shares Held
253MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.1 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.06 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$696 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$478 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$199 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.6B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...